Education
About Us
Working with TipRanks
Follow Us
PTC Therapeutics (PTCT)
NASDAQ:PTCT
PTCT Analyst Ratings
Moderate Buy
6 Buy
2 Hold
2 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
PTCT Stock 12 Month Forecast
Average Price Target
$63.89
▲(15.62% Upside)
| Highest Price Target$113.00 | Average Price Target$63.89 | Lowest Price Target$41.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Barclays
Reiterated
03/03/25
William Blair
Reiterated
02/28/25
Wells Fargo
Reiterated
02/28/25
J.P. Morgan
Reiterated
02/27/25
TD Cowen
Reiterated
02/27/25
RBC Capital
Reiterated
02/27/25
Bank of America Securities
Reiterated
02/27/25
Citi
Reiterated
02/11/25
Morgan Stanley
Reiterated
02/06/25
Cantor Fitzgerald
Reiterated
02/03/25
Leerink Partners
$50→$45
Hold
-18.57%
Downside
Reiterated
01/21/25
PTC Therapeutics (PTCT) Receives a Hold from Leerink Partners
Robert W. Baird
$52→$70
Buy
26.67%
Upside
Reiterated
12/03/24
PTC Therapeutics (PTCT) PT Raised to $70 at BairdBaird analyst Joel Beatty raised the price target on PTC Therapeutics (NASDAQ: PTCT) to $70.00 (from $52.00) while maintaining a Outperform rating.
Goldman Sachs
$32→$42
Sell
-24.00%
Downside
Reiterated
12/03/24
PTC Therapeutics (PTCT) PT Raised to $42 at Goldman SachsGoldman Sachs analyst Paul Choi raised the price target on PTC Therapeutics (NASDAQ: PTCT) to $42.00 (from $32.00) while maintaining a Sell rating.
Raymond James
―
Hold
―
Initiated
10/10/24
Raymond James resumes PTC Therapeutics (PTCT) at Market PerformRaymond James analyst Danielle Brill resumes coverage on PTC Therapeutics (NASDAQ: PTCT) with a Market Perform rating.
UBS
$47
Buy
-14.95%
Downside
Upgraded
08/26/24
PTC Therapeutics resumed with Buy from Neutral at UBSPTC Therapeutics resumed with Buy from Neutral at UBS
Best Analysts Covering PTC Therapeutics
Which Analyst Should I Follow If I Want to Buy PTCT and Sell After:
1 Month
xxx
Success Rate
12/17 ratings generated profit
Average Return
+4.51%
reiterated a xxx
rating 3 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 70.59% of your transactions generating a profit, with an average return of +4.51% per trade.
3 Months
xxx
Success Rate
11/15 ratings generated profit
Average Return
+8.79%
reiterated a xxx
rating 29 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 73.33% of your transactions generating a profit, with an average return of +8.79% per trade.
1 Year
Success Rate
15/17 ratings generated profit
Average Return
+37.88%
reiterated a buy rating 3 months ago
Copying Joel Beatty's trades and holding each position for 1 Year would result in 88.24% of your transactions generating a profit, with an average return of +37.88% per trade.
2 Years
xxx
Success Rate
16/17 ratings generated profit
Average Return
+60.84%
reiterated a xxx
rating 4 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 94.12% of your transactions generating a profit, with an average return of +60.84% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
PTCT Analyst Recommendation Trends
Rating
Oct 24
Nov 24
Dec 24
Jan 25
Feb 25
Strong Buy
4
2
1
3
3
Buy
7
11
16
16
16
Hold
14
18
21
18
11
Sell
5
5
8
7
7
Strong Sell
0
0
0
0
0
total
30
36
46
44
37
Each month's total comprises the sum of three months' worth of ratings.
PTCT Financial Forecast
PTCT Stock Forecast FAQ
What is PTCT’s average 12-month price target, according to analysts?
Based on analyst ratings, PTC Therapeutics’s 12-month average price target is $63.89.
What is PTCT’s upside potential, based on the analysts’ average price target?
PTC Therapeutics has 15.62% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is PTCT a Buy, Sell or Hold?
PTC Therapeutics has a consensus rating of Moderate Buy which is based on 6 buy ratings, 2 hold ratings and 2 sell ratings.
What is PTC Therapeutics’s price target?
The average price target for PTC Therapeutics is $63.89. This is based on 10 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $113.00 ,the lowest forecast is $41.00. The average price target represents 15.62% Increase from the current price of $55.26.
The highest analyst price target is $113.00 ,the lowest forecast is $41.00. The average price target represents 15.62% Increase from the current price of $55.26.
What do analysts say about PTC Therapeutics?
PTC Therapeutics’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 10 Wall Streets Analysts.
How can I buy shares of PTCT?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.